STAA STAAR Surgical Company

NASDAQ
$20.51

STAAR Surgical Company (STAA) is expected to report earnings on November 3, 2026, after the market close. The consensus earnings estimate is $0.06 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of -14.8% since its last earnings release on August 12, 2026.

STAAR Surgical Beat Expectations
Wednesday, August 12, 2026 · 4:01 PM ET
Earnings Date
3rd Quarter, Sep 2026
Nov 3
Tuesday · 4:00 PM ET
Earnings Whisper
-
vs $0.06 (GAAP)
Rev est $81.96M
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $22.62

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About STAAR Surgical Company

STAAR Surgical designs, develops, manufactures and sells implantable lenses for the eye. The Company is a maker of lenses used in corrective surgery, and it also makes lenses for use in surgery that treats cataracts.

Sector

Healthcare

Industry

Medical Appliances/Equipment

Held By 1 ETFs, by dollar flow

Charts powered in part by Lightweight Charts™ by TradingView.